Clinical TrialID 6137
Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer
NCT00003219
Breast Cancer
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 6137
- Evidence Id
- 6137
- Core Evidence Id
- 6137
- Source Clinical Trial Id
- 6123
- Herb2 Clinical Trial Id
- HBCT006123
- Nct Id
- NCT00003219
- Title
- Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer
- Status
- Completed
- Phase
- Phase 2
- Study Result
- No
- Study Condition
- Breast Cancer
- Study Type
- Interventional
- Study Design
- Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT
- Intervention
- DRUG: perillyl alcohol
- Intervention Allocation
- Intervention Model
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- Outcome Measure
- Sponsor Collaborator
- University of Wisconsin, Madison|National Cancer Institute (NCI)
- Funded By
- OTHER
- Location
- University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, 53792, United States
- Other Id
- CDR0000066080|R21CA072500|WCCC-CO-9611|NCI-T97-0068
- Start Date
- 1998-05
- Primary Completion Date
- 1998-05
- Completion Date
- 1998-05
- First Posted
- 2004-07-19
- Results First Posted
- Last Update Posted
- 2019-12-13
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00003219
- Title Cn
- Title En
- Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer
- Bilingual Status
- semi_complete